Acute Meningoencephalitis in Chronic Human Immunodeficiency Virus (HIV) Infection: Putative Central Nervous System Escape of HIV Replication

Clinical Infectious Diseases

Volumn 37, Issue 8, 2003, Pages 1107-1111

  Wendel, Karen A ^a   McArthur, Justin C ^b,c  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ACICLOVIR; AMPHOTERICIN; ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CEFOTAXIME; COTRIMOXAZOLE; DIDANOSINE; EFAVIRENZ; GADOLINIUM; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PRAZIQUANTEL; PREDNISOLONE; ZIDOVUDINE;

ACUTE KIDNEY FAILURE; ADULT; AIDS RELATED COMPLEX; ANTIBIOTIC THERAPY; ARTICLE; ASPIRATION PNEUMONIA; ATAXIA; AUDITORY HALLUCINATION; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BRAIN REGION; CASE REPORT; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; CONFUSION; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DISEASE SEVERITY; FEMALE; HEADACHE; HEMODIALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRACRANIAL HYPERTENSION; LUMBAR PUNCTURE; LYMPHOCYTE COUNT; MALE; MENINGOENCEPHALITIS; MICROBIOLOGICAL EXAMINATION; NAUSEA; NEUROLOGIC EXAMINATION; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TREATMENT OUTCOME; URINARY TRACT INFECTION; UVEITIS; VERTIGO; VIRUS LOAD; VIRUS REPLICATION; VOMITING;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; MENINGOENCEPHALITIS; MIDDLE AGED; VIRAL LOAD; VIRUS REPLICATION;

EID: 0142218457     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/378300     Document Type: Article

References (17)

1. Heaton RK, Grant I, Butters N, et al. The HNRC 500 - neuropsychology of HIV infection at different disease stages. J Int Neuropsychol Soc 1995; 1:231-51.
2. Lipton SA, Gendelman HE. Seminars in medicine of the Beth Israel Hospital, Boston: dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 1995; 332:934-40.
3. Sacktor N, Lyles RH, Skolasky R, et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 2001; 56:257-60.
4. Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001; 410:988-94.
5. Ellis RJ, Hsia K, Spector SA, et al. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol 1997;42:679-88.
6. Stankoff B, Calvez V, Suarez S, et al. Plasma and cerebrospinal fluid human immunodeficiency virus type-1 (HIV-1) RNA levels in HIV-related cognitive impairment. Eur J Neurol 1999; 6:669-75.
7. McArthur JC, McClernon DR, Cronin MF, et al. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol 1997; 42:689-98.
8. Cinque P, Vago L, Ceresa D, et al. Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis. AIDS 1998; 12:389-94.
9. Brew BJ, Pemberton L, Cunningham P, Law MG. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis 1997; 175:963-6.
10. Ellis RJ, Moore DJ, Childers ME, et al. Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. Arch Neurol 2002; 59:923-8.
11. Price RW, Staprans S. Measuring the "viral load" in cerebrospinal fluid in human immunodeficiency virus infection: window into brain infection? Ann Neurol 1997; 42:675-8.
12. Tyler KL, McArthur JC. Through a glass, darkly: cerebrospinal fluid viral load measurements and the pathogenesis of human immunodeficiency virus infection of the central nervous system. Arch Neurol 2002;59:909-12.
13. Tambussi G, Gori A, Capiluppi B, et al. Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid. Clin Infect Dis 2000;30:962-5.
14. Vanhems P, Allard R, Cooper DA, et al. Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive? Clin Infect Dis 1997;24:965-70 (erratum: Clin Infect Dis 1997; 25:352).
15. Gray F, Hurtrel M, Hurtrel B. Early central nervous system changes in human immunodeficiency virus (HIV)-infection. Neuropathol Appl Neurobiol 1993; 19:3-9.
16. Pialoux G, Fournier S, Moulignier A, Poveda JD, Clavel F, Dupont B. Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir. AIDS 1997; 11: 1302-3.
17. Martin C, Albert J, Hansson P, Pehrsson P, Link H, Sonnerborg A. Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17:214-9.